LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹51 Cr | ₹73 Cr | ₹73 Cr | ₹149 Cr | ₹137 Cr |
What is the latest Total Non-Current Liabilities ratio of LYKA LABS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹51 Cr |
Mar2023 | ₹73 Cr |
Mar2022 | ₹73 Cr |
Mar2021 | ₹149 Cr |
Mar2020 | ₹137 Cr |
How is Total Non-Current Liabilities of LYKA LABS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹51 Cr | -30.63 | |
Mar2023 | ₹73 Cr | 0.66 | |
Mar2022 | ₹73 Cr | -51.12 | |
Mar2021 | ₹149 Cr | 8.93 | |
Mar2020 | ₹137 Cr | - |
Compare Total Non-Current Liabilities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹421.1 Cr | 2.2% | 5.6% | 9.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,125.0 Cr | 0.1% | -9.1% | 13.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,358.0 Cr | -1.6% | 6.5% | 47% | Stock Analytics | |
CIPLA | ₹118,957.0 Cr | 0.3% | -4.6% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,087.0 Cr | -0.9% | -4.5% | 15.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,197.0 Cr | 0.4% | 6.5% | 4.1% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 2.2% |
5.6% |
9.8% |
SENSEX | -1% |
0.3% |
7.4% |
You may also like the below Video Courses